Botox vs Dysport vs Xeomin: What Actually Matters?

One of the most common questions in aesthetics is whether Botox, Dysport, or Xeomin is “better.” Patients often come in already leaning toward one because of social media, a friend’s experience, or something they heard online. But the truth is, the answer is usually more nuanced than brand preference alone. All three are forms of botulinum toxin type A, which means they work by temporarily relaxing targeted muscle movement. They are commonly used to soften repetitive expression lines in areas such as the forehead, frown lines, and crow’s feet. In that sense, they are all designed to accomplish a very similar goal. What tends to matter more is not just which one is used, but how it is used, how the individual responds to it, and whether the treatment plan was appropriate in the first place.

One of the biggest misconceptions is that one product is dramatically stronger or more superior than the others across the board. In reality, all three can produce beautiful results when selected and dosed properly. The differences tend to show up more in areas such as onset, diffusion, formulation preferences, and individual patient response rather than in some universal ranking of “best to worst.”

Botox is often the most recognized name because it has been around the longest in the public conversation. Many patients simply ask for Botox because it has become almost synonymous with wrinkle treatment. Dysport is also very popular and is sometimes perceived as having a slightly faster onset in some patients or a slightly broader spread in certain treatment areas, though that can vary. Xeomin is often appreciated for being a more purified formulation, which some patients and providers prefer depending on treatment history and personal philosophy.

However, what most patients actually care about is not the formulation itself. They care about questions like: Will it look natural? Will I still look like myself? How long will it last? Will it make me look heavy or frozen? Those outcomes are influenced just as much by injector judgment, facial anatomy, dosing strategy, and candidacy as they are by the product selected.

Another important point is that neurotoxins are not interchangeable unit for unit. The number of units used in Botox is not directly equivalent to the number of units used in Dysport, for example. This is one reason why price comparisons online can be misleading. A lower cost per unit does not necessarily mean lower cost overall or better value. The true comparison has to be based on how the product is dosed and how it performs in that specific treatment area.

Patient response can also vary. Some patients feel they get a slightly smoother onset with one product, or a more predictable duration with another. Others feel no meaningful difference at all. Over time, many people settle into the one that seems to perform most consistently for their face, not because it is objectively superior, but because it works well for them.

The most important thing to understand is that choosing between Botox, Dysport, and Xeomin is usually less important than choosing the right treatment plan and the right provider. A beautifully executed treatment with any of the three will almost always outperform a poorly planned treatment with the “popular” product.

At Aria Sonata Aesthetics, neurotoxin selection is not approached as a trend or a popularity contest. It is approached through anatomy, movement, patient goals, and long term planning. Because what actually matters most is not what the internet says is best. It is what performs best for your face, your goals, and the way you want to age over time.